Yet, whether CD53 mechanistically participates in the adaptive metabolic effects, which we previously demonstrated in GLUT8-deficient mice (e.g., protection from NAFLD and insulin resistance (32, 33, 38, 44, 53, 70, 71, 72)), remains to be fully determined. This evidence concerns the gene CD53 and Insulin resistance.